Your browser does not support JavaScript!

OAK BROOK, Ill. (October 5, 2022) — Novipax, a leading absorbent manufacturer for the fresh protein, produce, foodservice and healthcare markets, announced it will soon open a new manufacturing facility in El Paso, Texas.

The new facility will provide Novipax the resources needed to support its current and future growth plans, including continued growth into markets adjacent to protein, which include healthcare, produce and foodservice. The new facility’s location, in addition to its other strategically placed manufacturing facilities across the U.S., will offer Novipax’s current and prospective customers an optimal footprint to further strengthen its already reliable supply chain.

“This is an exciting new opportunity for us to continue our growth as a company and expand into new spaces that will help drive the future of our business,” stated Keith Schroeder, chief executive officer of Novipax. “We’re also looking forward to being a part of the El Paso community and partnering with them to not only create job opportunities for its residents, but to have a positive impact within the community as a whole.”

Novipax also announced that it will be discontinuing operations at its current La Verne, California, facility. These operations are planned to be moved to El Paso by June 2023.  During the transition, operations will be uninterrupted, as the commercial and customer service teams remain in place and continue to serve customers at the highest level.

January 15, 2024
Novipax Announces Strategic Partnership with Front1 Health Partners to Revolutionize Operating Room Safety and Efficiency
June 30, 2022
Mike Sugrue Joins Novipax As Vice President of Sales
December 15, 2021
Novipax’s Role In Lowering Food Waste Highlighted on EARTH TV Series